Abstract

Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications

Author(s): Gilbert John A

Issue: Sep/Oct 2009 - Veterinary Compounding

Page(s): 400-403

Download in electronic PDF format for $75

Abstract

The practice of pharmaceutical compounding may involve the dispensing of controlled substances, a subset of prescription drug products. In such cases, the Drug Enforcement Administration has authority to regulate and enforce pharmacy compounding in the U.S. through the Controlled Substances Act and Drug Enforcement Administration regulations, although the Drug Enforcement Administration expressly acknowledges that the agency does not establish medical standards or guidelines on the treatment of pain. There is a need to balance the interests of law enforcement in reducing the potential for prescription drug abuse without adversely affecting the need to ensure appropriate availability and access to pain medicine. Compounding pharmacies provide an important service to practitioners and their patients suffering from chronic pain and debilitating illness. Without access to pain medicine, a patient’s needs would go unmet, resulting in unnecessary pain and suffering.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2009 Pg. 400-403	Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Author(s): Gilbert John A
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Nov/Dec 2016 Pg. 457-458	U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Author(s):
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 94-96 View Sample	The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy Author(s): Miller David G
Nov/Dec 2012 Pg. 456-460	Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Author(s): Lyon Joanna
Jan/Feb 2003 Pg. 21-23	Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Author(s): Vail Jane
May/Jun 2005 Pg. 201-205	Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Author(s): Harrington Catherine A, Cauffield Jacintha
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Jul/Aug 2020 Pg. 296-297	Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Author(s): Brunner Scott
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
Jan/Feb 2005 Pg. 44-46	The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Author(s): Allen Loyd V Jr, Ashworth Lisa D
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Mar/Apr 2010 Pg. 131-133	Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs Author(s): Burke John, Hill Jeff
Sep/Oct 2015 Pg. 389-390	Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Author(s): Allen Loyd V Jr